Specifically, the new warning lists the risk of myocarditis as 8 cases per 1 million people who got the 2023-2024 COVID shots ...

FDA warning letters are nothing new in the cannabis industry. In fact, we here at Budding Trends have covered this topic a number of times (here, here, and here).Not resigned to playing the hits ...

Office of Prescription Drug Promotion (“OPDP”) posted a warning letter (the “Letter”)[1], issued on May 29, 2025, to Sprout ...

A potential FDA proposal would label Goldfish “medium” in saturated fat and sodium. (The placement and size of any U.S. label has yet to be determined.) The same product would bear stop-sign ...

The warning cautioned patients to stop using Veozah if they experienced any signs or symptoms suggesting liver injury.These include: new onset fatigue, nausea, vomiting, itchy skin, jaundice, pale ...

The agency issued the warning against 27 dry-eye products marketed under store brands such as CVS Health, Rite Aid, Target Up & Up and Walmart's Equate after finding harmful bacteria and ...

In new communication issued Tuesday, the FDA advised that women taking Veozah should undergo regular blood testing to monitor ...

FDA Issues Warning About Rare But Severe Reaction When Stopping Allergy ... Never miss a story — sign up for PEOPLE's free daily newsletter to stay up-to-date on the best of what PEOPLE has ...

Knockoff eye drops. The FDA's warning cited three specific counterfeit products posing as a legitimate product, Bausch + Lomb’s Lumify drops: South Moon, Rebright and FivFivGo.

The US Food and Drug Administration has placed its most serious warning – a so-called black-box warning – on a drug used to relieve menopausal hot flashes. The FDA says women who are taking ...

The U.S. Food and Drug Administration (FDA) has issued its most serious warning -- a black-box warning -- for Veozah, a medication used to relieve hot flashes in menopausal women, due to rare but ...